December 3, 2020 at 10:52AM

■■■■□ A weakness in the design of the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA and its successor, the Harmonized Screening Protocol v2.0 enables
these protocols to be circumvented using a generic obfuscation procedure. Insufficient cybersecurity mechanisms throughout the synthetic gene engineering pipeline allow a remote attacker to interfere with biological processes.